|
Jun 28
|
What's Going On With Merck Stock On Friday?
|
|
Jun 28
|
Merck’s pneumococcal vaccine gets CDC panel backing
|
|
Jun 28
|
Merck's (MRK) New Pneumococcal Jab Capvaxive Gets CDC Panel Vote
|
|
Jun 28
|
Merck Receives Positive EU CHMP Opinion for WINREVAIR™ (sotatercept) in Pulmonary Arterial Hypertension (PAH)
|
|
Jun 28
|
CDC’S ACIP Unanimously Recommends Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate Adults
|
|
Jun 27
|
Dow Jones Powerhouse Merck Dives On Surprise FDA Rejection
|
|
Jun 27
|
FDA Declines To Approve Merck-Daiichi Sankyo Partnered Lung Cancer Drug
|
|
Jun 26
|
Patritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party Manufacturer
|
|
Jun 26
|
Novo Nordisk, Eli Lilly still top 2 pharma stocks: Analyst
|
|
Jun 26
|
Capvaxive will enhance protection against pneumococcal disease in older adults
|
|
Jun 26
|
Pharma M&A: The top high value deals in 2023
|
|
Jun 25
|
USDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza
|
|
Jun 25
|
ASCO24: MSD’s ADC shows efficacy in lung and breast tumours
|
|
Jun 24
|
Merck (MRK) Increases Despite Market Slip: Here's What You Need to Know
|
|
Jun 24
|
3 Undervalued Pharma Stocks to Buy for Dividends and Capital Gains
|
|
Jun 24
|
Is Merck & Co., Inc. (MRK) a Strong Buy Right Now?
|
|
Jun 22
|
With 78% ownership of the shares, Merck & Co., Inc. (NYSE:MRK) is heavily dominated by institutional owners
|
|
Jun 21
|
The 30-stock secret: ‘Don’t fight Papa Dow’
|
|
Jun 20
|
Merck Is Partnering With America’s Largest HBCU To Launch a Collaborative Biotechnology Learning Center
|
|
Jun 18
|
MSD competes with Pfizer in pneumococcal vaccine market after FDA approval
|